Hasil Pencarian - Morihito Okada
- Menampilkan 1 - 20 hasil dari 44
- Ke Halaman Berikutnya
-
1
Current clinical trials with non-coding RNA-based therapeutics in malignant diseases: A systematic review oleh Masaoki Ito, Yoshihiro Miyata, Morihito Okada
Diterbitkan 2023-05-01
Artikel -
2
Psychological states regarding adjuvant chemotherapy in patients with non-small cell lung cancer oleh Takahiro Mimae, Miyako Satouchi, Morihito Okada
Diterbitkan 2022-01-01
Artikel -
3
Transition of Treatment for Ground Glass Opacity–Dominant Non-Small Cell Lung Cancer oleh Yoshinori Handa, Yasuhiro Tsutani, Morihito Okada
Diterbitkan 2021-04-01
Artikel -
4
-
5
Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma oleh Masaoki Ito, Yoshihiro Miyata, Kei Kushitani, Daisuke Ueda, Yukio Takeshima, Morihito Okada
Diterbitkan 2023-03-01
Artikel -
6
Dual-phase FDG PET/CT for predicting prognosis in operable breast cancer oleh Haruka Ikejiri, Shinsuke Sasada, Akiko Emi, Norio Masumoto, Takayuki Kadoya, Morihito Okada
Diterbitkan 2022-10-01
Artikel -
7
-
8
-
9
Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer oleh Atsushi Kagimoto, Yasuhiro Tsutani, Kei Kushitani, Takahiro Kambara, Takahiro Mimae, Yoshihiro Miyata, Yukio Takeshima, Morihito Okada
Diterbitkan 2021-06-01
Artikel -
10
-
11
Differences in immune response to anesthetics used for day surgery versus hospitalization surgery for breast cancer patients oleh Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Yuri Funaoka, Shoichiro Ohtani, Mitsuya Ito, Takayuki Kadoya, Morihito Okada
Diterbitkan 2017-09-01
Artikel -
12
Pathological high malignant grade is higher risk of recurrence in pN0M0 invasive lung adenocarcinoma, even with small invasive size oleh Masaoki Ito, Yoshihiro Miyata, Kei Kushitani, Atsushi Kagimoto, Daisuke Ueda, Yasuhiro Tsutani, Yukio Takeshima, Morihito Okada
Diterbitkan 2021-12-01
Artikel -
13
-
14
Usefulness of serum S100A4 and positron‐emission tomography on lung cancer accompanied by interstitial pneumonia oleh Atsushi Kagimoto, Yasuhiro Tsutani, Kei Kushitani, Takahiro Kambara, Takahiro Mimae, Yoshihiro Miyata, Yukio Takeshima, Morihito Okada
Diterbitkan 2023-02-01
Artikel -
15
Real-world clinical outcomes of nivolumab and taxane as a second- or later-line therapy for recurrent or unresectable advanced esophageal squamous cell carcinoma oleh Manato Ohsawa, Yoichi Hamai, Manabu Emi, Yuta Ibuki, Tomoaki Kurokawa, Toru Yoshikawa, Ryosuke Hirohata, Nao Kitasaki, Morihito Okada
Diterbitkan 2023-04-01
Artikel -
16
-
17
The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer oleh Noriko Goda, Shinsuke Sasada, Hideo Shigematsu, Norio Masumoto, Koji Arihiro, Hiroyoshi Nishikawa, Shimon Sakaguchi, Morihito Okada, Takayuki Kadoya
Diterbitkan 2022-04-01
Artikel -
18
-
19
A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with mutation (West Japan Oncology... oleh Ryota Shibaki, Hiroaki Akamatsu, Terufumi Kato, Kazumi Nishino, Morihito Okada, Tetsuya Mitsudomi, Kazushige Wakuda, Kenichi Yoshimura, Nobuyuki Yamamoto, Kazuhiko Nakagawa
Diterbitkan 2021-01-01
Artikel -
20
Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: a multicenter study oleh Tetsuya Isaka, Hiroyuki Adachi, Kotaro Murakami, Jun Miura, Noritake Kikunishi, Naoko Shigeta, Yujin Kudo, Yoshihiro Miyata, Morihito Okada, Norihiko Ikeda, Hiroyuki Ito
Diterbitkan 2023-11-01
Artikel